ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
ABBV Earnings: Everything you need to know about AbbVie’s Q4 report
CEREVEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cerevel Therapeutics - CERE
IMMUNOGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ImmunoGen, Inc. - IMGN
ABBV Earnings: A snapshot of AbbVie’s Q3 2023 report
AbbVie (ABBV) Q2 2023 Earnings: Key financials and quarterly highlights
AbbVie sees near-term slowdown; looks prepared to tackle patent expiration
AbbVie (ABBV) Q4 2022 Earnings: Key financials and quarterly highlights
ABBVIE INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of AbbVie Inc. - ABBV
AbbVie (ABBV) Q2 2022 Earnings Call Transcript
ABBV Earnings: Highlights of AbbVie’s Q2 2022 financial results
Despite generic threat, AbbVie (ABBV) remains a good long-term bet
ABBVIE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of AbbVie Inc. - ABBV
ABBVIE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against AbbVie, Inc. and Encourages Investors to Contact the Firm
AbbVie (ABBV) Q1 2022 Earnings Call Transcript
AbbVie (ABBV) Q4 2021 Earnings Call Transcript
AbbVie (ABBV) Earnings: Key financials and quarterly highlights
AbbVie (ABBV) stock research summary | Q3 2021
Earnings: AbbVie (ABBV) Q3 profit rises, beats estimates on higher revenues
AbbVie Inc (ABBV) Q2 2021 Earnings Call Transcript
Is Merck (MRK) stock still a buy after losing the vaccine race?
AbbVie (ABBV) Stock: Here’s what you need to know before investing
AbbVie Inc. (ABBV) Q4 2020 Earnings Call Transcript
AbbVie (ABBV) Earnings: 4Q20 Key Numbers
About · FAQs · StocksCafe © 2024 · Privacy · Terms